Home > Drug Search >
  • company_query: Alaxia
  •   > 
Drug Filter
Category:
chemistry (6) biology (16)
Status:
Approved (6) Phase Ⅱ (9) Phase Ⅰ (7)
Clinical Stage:
Pending (2) Active (13) Discontinued (1)
Bio-Type:
Cell therapy (1) Vaccine (1) Recombinant polypeptide (1) Recombinant cytokines (4) Whole antibody (6) Fusion protein (2)
Indication:
Advanced renal cell carcinoma (RCC) (1) Anemia (1) Basal cell carcinoma (BCC) (1) Breast cancer (1) Crohn's disease (2) Endometrial cancer (1) Penile cancer (1) Renal calculi (1) HCV infection (1) Hepatocellular carcinoma (HCC) (1) Cystinuria (1) Inflammatory bowel disease (1) Rabies (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Primary biliary cirrhosis (PBC) (1) Psoriasis (1) Psoriatic arthritis (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (4) Solid tumours (1) Venous thromboembolism (VTE) (1) Colorectal cancer (1) Ankylosing Spondylitis (AS) (1) Hypokalaemia (1) Cervical carcinoma (1) Neutropenia (1) Pressure sore (1) Staphylococcal infection (1) Advanced melanoma (1) Plaque psoriasis (1) Mesothelioma (1) Organ fibrosis (1) Sciatica (1) Inflammation (2) Human papillomavirus infections (HPV) (1)
Country:
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top